Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer With Macrovascular Invasion (HELIO-RT)

NCT07166406 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT07166406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07166406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial of IO-Based Systemic Treatment +/- Liver SBRT in Hepatocellular Cancer With Macrovascular Invasion (HELIO-RT)
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Recruiting
Start date
February 26, 2026
Completion date
March 10, 2034
Enrollment
226 (estimated)
Sites
139

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatocellular carcinoma, stage iii hepatocellular carcinoma ajcc v8, stage iv hepatocellular carcinoma ajcc v8